drugset / Trial / NCT06763731

Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery

NCT06763731 ↗

NaSingle-groupOpen-labelTreatment

Summary

Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.

Timeline

Start
2024-05-02
Primary completion
2027-01-14
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Systane Complete Other / unclassified — Topical

Indications

No indication recorded.